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More than ten years ago, the “danger theory” challenged
conservative immunology. At that time, the consensus was
that the immune system is activated by antigens recognized as
nonself. However, the self-nonself theory gave no explanation
why, for example, a fetus with obvious foreign antigens does
not lead tomaternal immune activationwhereas transplanted
organs do. In an attempt to resolve these apparent paradoxes,
the danger theory postulated that the immune system is
triggered by “danger signals” released upon tissue injury and
stress alerting the immune system that there is risk to the host
[1]. The “danger theory” is supported by the growing number
of endogenous ligands that can activate innate immune
receptors such as toll-like receptors, RIG-I-like receptors,
NOD-like receptors, and the inflammasome. However, it
poses the challenge of identifying such signals and the
mechanisms of their generation rigorously. Danger signals
or danger associated molecular patterns (DAMPs) identified
so far include factors like high-mobility group protein B1,
mitochondrial DNA, heat shock protein (HSP), interleukin-
1𝛼, adenosine triphosphate, reactive oxygen intermediates,
and uric acid [2].
A common feature of cardiovascular diseases, like
myocardial infarction, heart failure, atherosclerosis, and so
forth, is a robust inflammatory response. The reason for
an immunologic reaction in mostly nonimmune diseases is
not very well defined. However, the danger theory offers a
good explanation: tissue damage, for example, in myocardial
infarction, could lead to the release of danger signals and
thereby cause an immune response. Indeed, in the current
issue, several aspects of this process are highlighted: after
a general introduction into DAMPs in the cardiovascular
system [3],M.Ashri et al. discuss the theory of cardiotrophin-
1 as a secondary DAMP in obesity “Update on the pathophys-
iological activities of the cardiac molecule cardiotrophin-1 in
obesity,” whereas A. Schiopu et al. review S100A8 and S100A9,
members of the calgranulin family, as potential DAMP in
cardiovascular disease “S100A8 and S100A9: DAMPs at the
crossroads between innate immunity, traditional risk factors,
and cardiovascular disease.” F. van den Akker et al. highlight
that danger signals might influence the phenotype of mes-
enchymal stem cells and secondarily outcome after myocar-
dial infarction “Mesenchymal stem cell therapy for cardiac
inflammation: immunomodulatory properties and the influ-
ence of toll-like receptors.” A few original articles deal with the
role of oxidative stress as DAMP “Berberine protects against
palmitate-induced endothelial dysfunction: involvements of
upregulation of AMPK and eNOS and downregulation of
NOX4” and “Natural antioxidant-isoliquiritigenin ameliorates
contractile dysfunction of hypoxic cardiomyocytes via AMPK
signaling pathway” and with actin or chitinase 3-like 1 as
a trigger of immune activation in patients with advanced
atherosclerotic plaques “Actin is a target of T-cell reactivity
in patients with advanced carotid atherosclerotic plaques”
and “Increased expression of chitinase 3-like 1 in aorta of
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patients with atherosclerosis and suppression of atherosclerosis
in apolipoprotein E-knockout mice by chitinase 3-like 1 gene
silencing” or complement factorC3 asmarker of danger signal
activation in patients with heart failure “Complement c3c as
a biomarker in heart failure.” All manuscripts underline the
importance of danger signals in cardiovascular disease in
basic as well as clinical science.
Clinical Implications. DAMPs may have great diagnostic,
prognostic, and therapeutic potential. In theory, DAMPs
may indicate active tissue injury. Since DAMP levels are
related to the extent of injury, they may have prognostic
implications. When DAMPs are the most important trigger
for immune activation, pharmaceutical interference should
allow tailoring an immune response. However, it has to be
beard in mind that the activation of the immune system in
the context of tissue injury makes evolutionary sense and
is not necessarily negative. For example, after myocardial
infarction depletion of macrophages causes the scar not to be
cleared of cell debris and left ventricular thrombi to develop
leading to adverse outcome in animals and potentially also
in humans (Monocytes/macrophages prevent healing defects
and left ventricular thrombus formation after myocardial
infarction). Thus, an initial immune activation is necessary
for a coordinated pathophysiologic and beneficial response
to injury. However, a chronic immune activation might be
detrimental, as has been shown by several groups. Therefore,
timing will be crucial when interfering with DAMPs.
In conclusion, a better understanding of DAMPs in
cardiovascular disease might give us dual benefit: it will
help us to identify and treat patients at the very core of the
pathophysiological process. However, markers and potential
drug targets warrant further research.
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